Chimeric antigen receptor T-cell therapy in patients with malignant glioma-From neuroimmunology to clinical trial design considerations. - Gallus M; Young JS; Cook Quackenbush S; Khasraw M; de Groot J; Okada H (Neuro-oncology, 2025)